Drug Therapy Clinical Trials

6 recruiting

Drug Therapy Trials at a Glance

8 actively recruiting trials for drug therapy are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Phase 2 with 4 trials, with the heaviest enrollment activity in Bethesda, Gothenburg, and Guangzhou. Lead sponsors running drug therapy studies include Centre for Addiction and Mental Health, Centre hospitalier de l'Université de Montréal (CHUM), and Betta Pharmaceuticals Co., Ltd..

Browse drug therapy trials by phase

Treatments under study

About Drug Therapy Clinical Trials

Looking for clinical trials for Drug Therapy? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Drug Therapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Drug Therapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 2

Phase II Trial of Neoadjuvant Chemotherapy (NAC) Alone or in Combination With Immunotherapy Vaccine PRGN-2009 in Subjects With Newly Diagnosed HPV-Associated Oropharyngeal (Head and Neck) Cancer

Squamous Cell Carcinoma of the Head and NeckDrug TherapyOropharynx+2 more
National Cancer Institute (NCI)70 enrolled1 locationNCT06223568
Recruiting
Phase 4

"Extended" (Alternate Day) Antipsychotic Dosing

Drug TherapySchizophrenia and Related DisordersAntipsychotic Agents+1 more
Centre for Addiction and Mental Health120 enrolled1 locationNCT04478838
Recruiting
Phase 2

Efficacy of Trazodone to Treat Insomnia in Older Adults (TRADITION Study)

Older PeopleDrug TherapyInsomnia Chronic
Centre hospitalier de l'Université de Montréal (CHUM)40 enrolled1 locationNCT06983080
Recruiting
Phase 2

Sequential Chemotherapy With Befotertinib in Non-Small Cell Lung Cancer (NSCLC) Patients With Resistance to Third-Generation EGFR-TKI

NSCLCEGFRAdjuvant Drug Therapy
Betta Pharmaceuticals Co., Ltd.28 enrolled2 locationsNCT07181499
Recruiting
Not Applicable

Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs

HypertensionDrug TherapyPrimary Health Care
Vastra Gotaland Region120 enrolled3 locationsNCT05322967
Recruiting
Phase 2

Efficacy and Safety of Trifluridine/Tipiracil Combined With Fufuquitinib for Third-line Treatment of mCRC

Metastatic Colorectal CancerDrug Therapy
First Affiliated Hospital of Wenzhou Medical University200 enrolled1 locationNCT06485713
Recruiting
Phase 3

The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity

Cardiotoxicity Induced by Drug Therapy for Breast Cancer
Zhejiang Cancer Hospital276 enrolled1 locationNCT06214195
Recruiting

Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer Registry

SurgeryNeoplasmsRadiotherapy+2 more
Fudan University500,000 enrolled1 locationNCT04996732